Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.0 - $334.83 $0 - $10,044
-30 Closed
0 $0
Q4 2023

Feb 09, 2024

BUY
$160.99 - $215.69 $4,507 - $6,039
28 Added 1400.0%
30 $6,000
Q3 2023

Nov 13, 2023

SELL
$194.33 - $283.97 $5,246 - $7,667
-27 Reduced 93.1%
2 $0
Q2 2023

Aug 10, 2023

BUY
$223.05 - $302.68 $6,468 - $8,777
29 New
29 $8,000
Q4 2022

Feb 13, 2023

SELL
$204.38 - $296.82 $3.88 Million - $5.64 Million
-19,008 Reduced 99.83%
32 $7,000
Q3 2022

Nov 09, 2022

BUY
$195.21 - $310.53 $3.71 Million - $5.91 Million
19,023 Added 111900.0%
19,040 $5.29 Million
Q2 2022

Aug 10, 2022

BUY
$115.91 - $214.48 $1,970 - $3,646
17 New
17 $3,000
Q1 2022

May 12, 2022

SELL
$127.96 - $207.36 $639 - $1,036
-5 Closed
0 $0
Q4 2021

Jan 27, 2022

SELL
$165.13 - $241.83 $7,926 - $11,607
-48 Reduced 90.57%
5 $1,000
Q3 2021

Nov 12, 2021

BUY
$163.99 - $235.57 $8,691 - $12,485
53 New
53 $11,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.